Keywords = Background: Benign prostatic hyperplasia (BPH) is a noncancerous increase of the size of the prostate gland. The two main medication classes for BPH management are alpha blockers and 5α -reductase inhibitors .Urinary bladder stones account for 5% of
| Number of Articles: 1 | ||
| 1 | MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY | |
| Volume 24, Issue 4, July 2018, Page 354-358 | ||
| Mohammed Alaa Aden Mohammed; Ahmed Ragab Ali; Mohammed Mahmoud Seleem; Abraheem Mohammed Ali | ||
View on SCiNiTO